Reviews & Analysis

Filter By:

  • The National Institute of Allergy and Infectious Diseases (NIAID) hosted a symposium on ‘AI and Immunology: Exploring Challenges and Opportunities’. The event considered how artificial intelligence (AI) can advance research on the multi-scale, adaptive immune system to improve human health, covering basic research and clinical use cases, data and AI model fundamentals.

    • Anupama E. Gururaj
    • Richard H. Scheuermann
    • Dawei Lin
    Meeting Report
  • A novel method that recreates human intestinal organoids containing viable tissue-resident memory T cells will facilitate the exploration of tissue–immune interactions and clinically relevant immune pathologies.

    • Kevin Man
    • Axel Kallies
    News & Views
  • The G396R coding variant in IGHG1, which encodes membrane-bound IgG1 heavy chain, might have arisen within the Southeast Asian population as a potential evolutionary event on an archaic haplotype background. This variant potentiates immune resilience against various life-threatening organisms, illustrating the interplay of human evolution and immune adaptation.

    Research Briefing
  • We integrated single-cell RNA-sequencing data to provide comprehensive profiles of the cellular composition of the tumor microenvironment and identify their underlying genetic determinants across 23 cancer types. We used this resource to delineate the biological mechanisms by which genetic variants shape the cellular composition of the tumor microenvironment.

    Research Briefing
  • Effector CD8+ T cells with cytotoxic ability are crucial for immunotherapy success. Two studies show that salt (NaCl) supplementation can enhance the effector function of CD8+ T cells and boost their antitumor responses.

    • Karina L. Hajdu
    • Lorène Rousseau
    • Ping-Chih Ho
    News & Views
  • Immunocytokines are cytokine-based fusion proteins with therapeutic potential. New CD45-targeted immunocytokines can reprogram systemic anti-tumor immunity by prolonged retention on T cells and dendritic cells while minimizing systemic toxicities through intratumoral delivery.

    • Nils Wellhausen
    • Saar Gill
    News & Views
  • Tumor cells in emerging cancers modify their gene expression to avoid immune control, a process known as immunoediting. We found that genome-wide gene expression changes in breast tumors after oncogene induction in genetically engineered mice were dominated by the epigenetic repression of innate and adaptive immune genes. Immunoevasion by tumors was reversed by a DNA methyltransferase inhibitor.

    Research Briefing
  • Mucosal vaccine boosters are expected to enhance protection against SARS-CoV-2 infection. A study now reveals that the delivery device — through either intranasal sprayers or nebulizers — also influences the mucosal immunity and protection efficacy in non-human primates.

    • Fanchong Jian
    • Yunlong Cao
    News & Views
  • Profiling of T cell responses in the lungs of patients with pneumonia revealed that early and persistent enrichment of T cells correlates with survival from SARS-CoV-2 pneumonia. Notably, lung T cells with an interferon-stimulated profile and specific for SARS-CoV-2 structural proteins support survival, whereas those that gain a nuclear factor-κB (NF-κB)-driven inflammatory profile and are directed against nonstructural proteins were associated with poor clinical outcomes.

    Research Briefing
  • The AIRE protein drives the expression of tissue-restricted self-antigens, required to induce immune tolerance for self-proteins. New work shows the importance of an external interaction between AIRE and the transcriptional activator CBP/p300, and an internal competition for nuclear-condensate formation.

    • Michael R. Waterfield
    • Mark S. Anderson
    News & Views
  • Longitudinal sampling of human lymph nodes using fine-needle aspiration after influenza or SARS-CoV-2 vaccination reveals substantial durability and transcriptional reprogramming of follicular helper T cells over time.

    • Cody S. Nelson
    • Peter T. Sage
    News & Views
  • A lung-specific fibroblast that normally provides a niche for alveolar cells has been identified as the predominant source of emergent inflammatory and fibrotic fibroblast subsets. This finding has major implications for the treatment of lung diseases.

    • Christopher D. Buckley
    • Kim S. Midwood
    News & Views
  • Patients with Crohn’s disease display an altered serum IgG glycosylation signature that is detectable many years before clinical diagnosis and is associated with increased levels of pathogenic anti-mannan antibodies. The altered IgG glycoforms activate innate immune cells, in a preclinical phase, promoting the transition to intestinal inflammation.

    Research Briefing